Although the prognostic impact of EpCAM differs depending on the type of cancer, Seeber et al. demonstrated that high EpCAM expression in colon cancer cells was associated with aggressive tumor biology, causing multiple recurrences in the early phase following surgery in patients with CRC26. This evidence concerns the gene EPCAM and colonic neoplasm.